StockData
Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc. (AGIO) stock

AGIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/308% above fair value
$29.89−0.26 (-0.86%)

Close on Nov 17, 2026Market cap $1.78BP/E –Yield –

Agios Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Agios Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was -418.2%. For fiscal 2025 it was -764.0%, against 1845.9% the year before. The highest annual figure on record is 1845.9% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-764.0%−2609.9
FY2024Dec 31, 20241845.9%+3158.6
FY2023Dec 31, 2023-1312.6%+315.2
FY2022Dec 31, 2022-1627.8%−1278.9
FY2019Dec 31, 2019-349.0%+17.6
FY2018Dec 31, 2018-366.6%+365.0
FY2017Dec 31, 2017-731.6%−447.6
FY2016Dec 31, 2016-284.0%−84.8
FY2015Dec 31, 2015-199.1%−117.3
FY2014Dec 31, 2014-81.9%+72.4
FY2013Dec 31, 2013-154.2%−74.2
FY2012Dec 31, 2012-80.1%+28.5
FY2011Dec 31, 2011-108.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-225.1%+674.3
Q1 FY2026Mar 31, 2026-477.7%+545.5
Q4 FY2025Dec 31, 2025-541.1%+358.5
Q3 FY2025Sep 30, 2025-803.1%−11377.7
Q2 FY2025Jun 30, 2025-899.4%+216.3
Q1 FY2025Mar 31, 2025-1023.3%−27.4
Q4 FY2024Dec 31, 2024-899.6%+451.1
Q3 FY2024Sep 30, 202410574.7%+11809.0
Q2 FY2024Jun 30, 2024-1115.7%+132.9
Q1 FY2024Mar 31, 2024-995.8%+448.6
Q4 FY2023Dec 31, 2023-1350.7%−2198.2
Q3 FY2023Sep 30, 2023-1234.3%+1090.7
Q2 FY2023Jun 30, 2023-1248.6%+396.1
Q1 FY2023Mar 31, 2023-1444.4%+9946.7
Q4 FY2022Dec 31, 2022847.5%+1069.2
Q3 FY2022Sep 30, 2022-2325.0%−2039.8
Q2 FY2022Jun 30, 2022-1644.7%−1402.4
Q1 FY2022Mar 31, 2022-11391.1%−11344.9
Q4 FY2020Dec 31, 2020-221.7%+67.1
Q3 FY2020Sep 30, 2020-285.2%+122.8
Q2 FY2020Jun 30, 2020-242.3%+176.8
Q1 FY2020Mar 31, 2020-46.2%+261.7
Q4 FY2019Dec 31, 2019-288.8%+17.0
Q3 FY2019Sep 30, 2019-408.0%+214.9
Q2 FY2019Jun 30, 2019-419.0%−248.9
Q1 FY2019Mar 31, 2019-307.9%+728.6
Q4 FY2018Dec 31, 2018-305.8%+595.1
Q3 FY2018Sep 30, 2018-622.9%+56.3
Q2 FY2018Jun 30, 2018-170.1%+562.2
Q1 FY2018Mar 31, 2018-1036.6%−406.9
Q4 FY2017Dec 31, 2017-901.0%−798.5
Q3 FY2017Sep 30, 2017-679.1%+20.2
Q2 FY2017Jun 30, 2017-732.3%–
Q1 FY2017Mar 31, 2017-629.7%–
Q4 FY2016Dec 31, 2016-102.4%–
Q3 FY2016Sep 30, 2016-699.3%–

More Agios Pharmaceuticals figures

See a number that looks wrong?